Zoltan Greff

Budapest, BU, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma.

Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma.

Journal: Cell reports

Published: February 17, 2017

Correction: Targeting Vascular Endothelial Growth Factor Receptor 2 and Protein Kinase D1 Related Pathways by a Multiple Kinase Inhibitor in Angiogenesis and Inflammation Related Processes In Vitro.

Correction: Targeting Vascular Endothelial Growth Factor Receptor 2 and Protein Kinase D1 Related Pathways by a Multiple Kinase Inhibitor in Angiogenesis and Inflammation Related Processes In Vitro.

Journal: PloS one

Published: December 18, 2015

Novel compounds reducing IRS-1 serine phosphorylation for treatment of diabetes.

Novel compounds reducing IRS-1 serine phosphorylation for treatment of diabetes.

Journal: Bioorganic & medicinal chemistry letters

Published: October 02, 2015

[Pyrido[2,3-b]pyrazines inhibiting both erlotinib-sensitive and erlotinib-resistant cell lines, and their preparation via regioselective condensation reaction].

[Pyrido[2,3-b]pyrazines inhibiting both erlotinib-sensitive and erlotinib-resistant cell lines, and their preparation via regioselective condensation reaction].

Journal: Acta pharmaceutica Hungarica

Published: December 05, 2014

Targeting vascular endothelial growth factor receptor 2 and protein kinase D1 related pathways by a multiple kinase inhibitor in angiogenesis and inflammation related processes in vitro.

Targeting vascular endothelial growth factor receptor 2 and protein kinase D1 related pathways by a multiple kinase inhibitor in angiogenesis and inflammation related processes in vitro.

Journal: PloS one

Published: September 30, 2014

Anticytolytic screen identifies inhibitors of mycobacterial virulence protein secretion.

Anticytolytic screen identifies inhibitors of mycobacterial virulence protein secretion.

Journal: Cell host & microbe

Published: June 06, 2014

Synthesis and evaluation of phosphorus containing, specific CDK9/CycT1 inhibitors.

Synthesis and evaluation of phosphorus containing, specific CDK9/CycT1 inhibitors.

Journal: Journal of medicinal chemistry

Published: April 19, 2014

Development and biochemical characterization of EGFR/c-Met dual inhibitors

Development and biochemical characterization of EGFR/c-Met dual inhibitors

Journal: Acta pharmaceutica Hungarica

Published: March 01, 2014

Development and study of structure-activity relationship of drugs against Mycobacterium tuberculosis

Development and study of structure-activity relationship of drugs against Mycobacterium tuberculosis

Journal: Acta pharmaceutica Hungarica

Published: December 28, 2013

Discovery and Biological Evaluation of Novel Dual EGFR/c-Met Inhibitors.

Discovery and Biological Evaluation of Novel Dual EGFR/c-Met Inhibitors.

Journal: ACS medicinal chemistry letters

Published: August 25, 2013

Developing FGFR inhibitors as potential anti-cancer agents

Developing FGFR inhibitors as potential anti-cancer agents

Journal: Acta pharmaceutica Hungarica

Published: August 10, 2013

Developing FGFR4 inhibitors as potential anti-cancer agents via in silico design, supported by in vitro and cell-based testing.

Developing FGFR4 inhibitors as potential anti-cancer agents via in silico design, supported by in vitro and cell-based testing.

Journal: Current medicinal chemistry

Published: November 30, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026